After a rocky start to the spring, Wall Street came roaring back in May. President Trump’s softened tariff stance reignited ...

Fintel reports that on June 3, 2025, Oppenheimer initiated coverage of Axsome Therapeutics (NasdaqGM:AXSM) with a Outperform ...

Oppenheimer increased its price target for Trevi Therapeutics Inc. (NASDAQ:TRVI) to $23 from $20, while maintaining an ...

Chipmaker Broadcom is set to report quarterly results after the closing bell Thursday, with Wall Street analysts expecting ...

Discover which Christopher Nolan blockbuster tops the list as his most expensive production, reaching a quarter of a billion ...

Long before blockbusters like Oppenheimer and Interstellar, Christopher Nolan directed this brilliant but overlooked thriller ...

Oppenheimer analyst Rick Schafer reiterated a Buy rating on NVIDIA Corporation (NASDAQ:NVDA) and set a price target of ...

Little is known about the currently untitled film yet, other than the fact that Chazelle, who is perhaps best known for ...

All told, Oppenheimer analyst Rick Schafer feels good about Nvidia's positioning coming out of earnings. "The best house on the best block, \[Nvidia\] remains arguably best positioned in AI, ...

Nvidia (NASDAQ:NVDA) is expected to post strong fiscal first-quarter earnings on May 28, though its outlook may be tempered ...